BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Artificial Intelligence

Leo Cancer Care Advances Upright Radiation Therapy Experience for Children

Leo Cancer Care has announced plans to further invest in the treatment experience for children undergoing radiation therapy. Following the world's fi...

September 29, 2026 | News

XtalPi Files US FDA IND for AI-Designed Gut-Restricted Pan-TRK Inhibitor KQTD-126

This milestone marks the first IND submission from XtalPi's proprietary pipeline, recently unveiled in its interim results, validating the company's ...

September 28, 2026 | News

Nutshell Therapeutics Secures FDA IND Clearance for AI-Discovered NRF2 Degrader NTS231

Nutshell Therapeutics (Shanghai) Co., Ltd. ("Nutshell Therapeutics"), an innovative biotech company focused on AI-driven allosteric drug discovery, announc...

September 28, 2026 | News

Earendil Labs, Genentech Ink $1.5B+ Deal to Develop AI-Driven Bispecific Antibodies

Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research collaboration with Genentech, a member o...

September 25, 2026 | News

Tech Mahindra, Verato Partner to Strengthen Data Foundations for AI-Driven Healthcare

The partnership gives U.S. health systems, payers, pharma, and device makers a trusted way to match patient, provider, and member records as they modernize...

September 25, 2026 | News

Tsingke Launches High-Throughput Validation Workflow for AI-Designed Proteins and Antibodies

Tsingke announced an integrated high-throughput validation workflow designed to help researchers experimentally evaluate large libraries of AI-designed pro...

September 24, 2026 | News

Evinova, Lothar Medical Partner to Digitise Respiratory Clinical Trials

Evinova, a global leader in AI-native clinical development technology, announced a strategic partnership with Lothar Medical to help transform the ex...

September 08, 2026 | News

SIBIONICS Showcases AI-Powered GS3 Glucose Monitoring, Advances Integrated Diabetes Care at Melbourne Congress

SIBIONICS showcased its sensor innovation and AI-powered glucose monitoring at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress, held in Melbour...

September 01, 2026 | News

HiRO and Differentia Join Forces to Advance AI-Powered Clinical Trial Simulation and Digital Twins

Memorandum of Understanding establishes a framework for joint development of clinical trial simulation capabilities The partnership unites global clinic...

August 31, 2026 | News

Sanyou Bio Launches AI-Powered Clicklinks to Accelerate Global Drug Discovery and Preclinical Development

Sanyou Biopharmaceuticals Co., Ltd. (hereinafter referred to as "Sanyou Bio"), announced the official launch of Clicklinks, an AI-STAL and SAI-DA pow...

August 31, 2026 | News

Monod Bio, SignalChem Biotech Ink Licensing Deal to Advance AI-Designed Protein Technologies

Monod Bio, a Seattle-based AI-enabled protein design company, and SignalChem Biotech Inc., a wholly-owned subsidiary of Sino Biological, Inc. announced a n...

August 28, 2026 | News

GenScript CEO Sherry Shao Sees AI-Enabled Drug Discovery as Key Growth Engine After Strong H1 2026

Adjusted net profit surges 203.3% as Gene-to-Protein generates two-thirds of GenScript Life Science Group revenue GenScript Biotech Corporation (HKEX: 154...

August 20, 2026 | Company results

Singapore Launches First Biological Data Centre Prototype to Advance Energy-Efficient AI Computing

DayOne Data Centers Limited ("DayOne"), a Singapore-headquartered global digital infrastructure platform, today launched Singapore's first Biological Data ...

August 18, 2026 | News

Kyowa Kirin Taps Cognizant and Benchling to Build AI-Powered Drug Discovery Foundation in Japan

Cognizant announced that it will support the introduction and implementation of Benchling, the AI platform for R&D at Tokyo Research Park and Fuji Rese...

August 18, 2026 | News

Stay Connected